author-photo

Robert Kimutai

Drugs for Neglected Diseases Initiative

11

Papers

416

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa.

2021 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (3)
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia

2019 PLOS Neglected Tropical Diseases
Show All
- Source
- Cite
- Save
Citations (27)
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial

2018 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (21)
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme

2017 Clinical Drug Investigation
Show All
- Source
- Cite
- Save
Citations (32)
PILOTING DHIS2 SYSTEM IN VISCERAL LEISHMANIASIS SURVEILLANCE

2017 BMJ Global Health
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.

2016 PLOS Neglected Tropical Diseases
Show All
- Source
- Cite
- Save
Citations (80)
Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial.

2014 PLOS Neglected Tropical Diseases
Show All
- Source
- Cite
- Save
Citations (57)
Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial

2012 PLOS Neglected Tropical Diseases
Show All
- Source
- Cite
- Save
Citations (95)